MyAverix Finance MyAverix Finance

HK

Huakang Biomedical Holdings Co Ltd (8622)

Huakang Biomedical Holdings Co Ltd (8622) is listed on HK. As of 2026-05-21, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-21

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 8622

P/E ratio
18.00

Huakang Biomedical Holdings Co Ltd (8622) — FAQ

What is 8622's P/E ratio?

The price-to-earnings (P/E) ratio for Huakang Biomedical Holdings Co Ltd (8622) is 18.00 (data as of 2026-05-21).

Does Huakang Biomedical Holdings Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Huakang Biomedical Holdings Co Ltd (8622). Check the MyAverix Finance app for the latest dividend data.

What exchange is 8622 listed on?

8622 is listed on HK.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play